drug pricing

The Readout Meghana Keshavan

STAT Plus: Element Biosciences raises another massive round

The Readout Elaine Chen

STAT Plus: Can you get satiety with GLP-1s without the nausea?

The Readout Elaine Chen

STAT Plus: uniQure shares soar on Huntington’s data

The Readout Elaine Chen

STAT Plus: Lilly’s obesity drug looks more potent than Novo’s in observational study

Pharmalot Ed Silverman

STAT Plus: FTC report finds PBMs profit at the expense of patients and independent pharmacies

The Readout Meghana Keshavan

STAT Plus: The biotech news you missed this week

The Readout Meghana Keshavan

STAT Plus: Will Medicare finally begin covering weight loss drugs like Zepbound and Wegovy?

Politics Rachel Cohrs Zhang and Sarah Owermohle

STAT Plus: Biden and Trump spar over Medicare and abortion in a presidential debate filled with mistakes and falsehoods

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: Key health care topics to watch out for at the Biden-Trump debate

The Readout Elaine Chen

STAT Plus: Exclusive: European VC Forbion hires Dyne CEO, expands in US

The Readout Elaine Chen

STAT Plus: Intellia says its CRISPR-based therapy can be redosed

The Readout Elaine Chen

STAT Plus: One firm, two conflicting takes on Alnylam’s HELIOS-B 

The Readout Meghana Keshavan

STAT Plus: The findings from Alnylam’s highly anticipated readout  

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about FDA approval for Sarepta drug, MSF closing access campaign and more

The Readout Meghana Keshavan

STAT Plus: Can JAK inhibitors bolster checkpoint inhibitors? 

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about Lilly lawsuits, Novo Nordisk fires and much more

The Readout Elaine Chen

STAT Plus: Lilly takes more actions against unapproved versions of Mounjaro

The Readout Adam Feuerstein

STAT Plus: A biotech’s binary bet ends badly

The Readout Meghana Keshavan

STAT Plus: FDA offers new guidelines for Covid-19 vaccine

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about abortion pill access, employer coverage of GLP-1 drugs and more

The Readout Elaine Chen

STAT Plus: J.P. Morgan has officially jumped into early stage biotech investing

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: Does Sanders have the votes to subpoena a Novo exec?

The Readout Meghana Keshavan

With Avidity and Pfizer, gene therapy enters a phase

The Readout Elaine Chen

STAT Plus: What do Parkinson’s and obesity have in common?

First Opinion Jake Frenz

The J&J lawsuit should be a wakeup call to the PBM industry — and to companies everywhere

The Readout Elaine Chen

Eli Lilly’s Alzheimer’s candidate, Bob Langer’s new startup, and other biotech news you need to know

The Readout Meghana Keshavan

The biotech news you missed from the weekend

The Readout Meghana Keshavan

STAT Plus: Vanda Pharmaceuticals has another suitor

The Readout Elaine Chen

Novavax will be able to supply Covid-19 vaccines this fall